These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 1779916)
1. May the alterations in lipid fluidity-mediated platelet hypersensitivity contribute to accelerated aging of platelets in diabetes mellitus? Watala C Med Hypotheses; 1991 Oct; 36(2):142-5. PubMed ID: 1779916 [TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus alters the effect of peptide and protein ligands on membrane fluidity of blood platelets. Watala C; Gwoździński K; Pluskota E; Pietrucha T; Walkowiak B; Trojanowski Z; Cierniewski CS Thromb Haemost; 1996 Jan; 75(1):147-53. PubMed ID: 8713794 [TBL] [Abstract][Full Text] [Related]
3. Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus. Watala C Curr Pharm Des; 2005; 11(18):2331-65. PubMed ID: 16022671 [TBL] [Abstract][Full Text] [Related]
4. Membrane fluidity is related to the extent of glycation of proteins, but not to alterations in the cholesterol to phospholipid molar ratio in isolated platelet membranes from diabetic and control subjects. Winocour PD; Watala C; Kinglough-Rathbone RL Thromb Haemost; 1992 May; 67(5):567-71. PubMed ID: 1519216 [TBL] [Abstract][Full Text] [Related]
5. Reduced membrane fluidity and increased glycation of membrane proteins of platelets from diabetic subjects are not associated with increased platelet adherence to glycated collagen. Winocour PD; Watala C; Kinlough-Rathbone RL J Lab Clin Med; 1992 Dec; 120(6):921-8. PubMed ID: 1453113 [TBL] [Abstract][Full Text] [Related]
6. Modified fluidity and lipid composition in lipoproteins and platelet membranes from diabetic patients. Rabini RA; Ferretti G; Galassi R; Taus M; Curatola G; Tangorra A; Fumelli P; Mazzanti L Clin Biochem; 1994 Oct; 27(5):381-5. PubMed ID: 7867216 [TBL] [Abstract][Full Text] [Related]
7. Decreased platelet membrane fluidity due to glycation or acetylation of membrane proteins. Winocour PD; Watala C; Perry DW; Kinlough-Rathbone RL Thromb Haemost; 1992 Nov; 68(5):577-82. PubMed ID: 1455404 [TBL] [Abstract][Full Text] [Related]
11. Possible mechanisms of the altered platelet volume distribution in type 2 diabetes: does increased platelet activation contribute to platelet size heterogeneity? Watala C; Boncler M; Pietrucha T; Trojanowski Z Platelets; 1999; 10(1):52-60. PubMed ID: 16801071 [TBL] [Abstract][Full Text] [Related]
12. Effects of calcium, lanthanum, and temperature on the fluidity of spin-labeled human platelets. Sauerheber RD; Zimmermann TS; Esgate JA; VanderLaan WP; Gordon LM J Membr Biol; 1980; 52(3):201-19. PubMed ID: 6247493 [TBL] [Abstract][Full Text] [Related]
13. Comparison between in vitro lipid peroxidation in fresh sheep platelets and peroxidative processes during sheep platelet ageing under storage at 4 degrees C. Martín-Valmaseda EM; Sánchez-Yagüe J; Rodríguez MC; Gómez FP; Llanillo M Biochim Biophys Acta; 1999 Jul; 1419(2):313-24. PubMed ID: 10407082 [TBL] [Abstract][Full Text] [Related]
14. Platelet membrane lipid fluidity and intraplatelet calcium mobilization in type 2 diabetes mellitus. Watala C; Boncler M; Golański J; Koziołkiewcz W; Trojanowski Z; Walkowiak B Eur J Haematol; 1998 Nov; 61(5):319-26. PubMed ID: 9855247 [TBL] [Abstract][Full Text] [Related]
15. Membrane fluidity, membrane lipid pattern, and cytosolic Ca2+ content in platelets from a group of type II diabetic patients with macrovascular complications. Caimi G; Lo Presti R; Montana M; Canino B; Ventimiglia G; Romano A; Catania A; Sarno A Diabetes Care; 1995 Jan; 18(1):60-3. PubMed ID: 7698049 [TBL] [Abstract][Full Text] [Related]